Skip to main content

The Pink Pearl Foundation’s events team includes Ashleigh Meilach, left, Emma Toth and Courtney McNamara.

The donor: Elise Gasbarrino

The gift: Founding the Pink Pearl Foundation

The reason: To fund support programs for young women diagnosed with cancer

Story continues below advertisement

Elise Gasbarrino was on a student co-op program in Ottawa 10 years ago when she developed sharp pains in her abdomen. She returned home to Thorold, Ont., and medical tests revealed she had ovarian cancer.

Ms. Gasbarrino, who was 21 years old at the time, underwent surgery to remove a tumour, as well as chemotherapy.

"It was a very difficult time made easier by family and friends," recalled Ms. Gasbarrino, who is cancer-free and works as an account executive for Burberry in Toronto and New York.

During her treatments and recovery, Ms. Gasbarrino noticed that there were few support services for women her age. That led her to establish the Pink Pearl Foundation, a non-profit organization that funds in-hospital programs, retreats and scholarships for women between the ages of 18 and 40 who have been diagnosed with cancer. So far, the group has raised $185,000 in total.

Ms. Gasbarrino said she chose the name because pink pearls are strong and feminine. The foundation, she added, "has been amazing. It's definitely the coolest thing I've ever done."

pwaldie@globeandmail.com

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies